Process for coupling biological substances by covalent bonds

• US 4,193,982 A
• Filed: 12/01/1976
• Issued: 03/18/1980
• Est. Priority Date: 12/05/1975
• Status: Expired due to Term

• Current Assignee: Etablissement Declare D'Utilite Publique DITI Institut Pasteur
• Original Assignee: Etablissement Declare D'Utilite Publique DITI Institut Pasteur
• Inventors: Avrameas, Stratis, Ternynck, Therese M. F.
• Primary Examiner(s): Fagelson, Anna P.
• Application Number:
  US05/746,552
• Time in Patent Office: 1,203 Days
• Field of Search: 424/8, 424/11, 424/12, 424/13, 424/177, 260/112 R, 260/112 B, 260/112.5, 260/121, 195/63, 195/103.5 A, 23/230 B
• US Class Current: 530/391.1
• CPC Class Codes: G01N 2474/20 Immunohistochemistry assay
• CPC Class Codes: G01N 33/531 Production of immunochemical test materials
• CPC Class Codes: G01N 33/532 Production of labelled immunochemicals
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 530/866 involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Abstract

A process for coupling biological substances by covalent bonds that involves the use of benzoquinone as cross-linking agent in large excess compared with the substance to be activated. The activation reaction is realized in a homogeneous liquid medium. The process makes it possible, for example, to couple antibodies to enzymes for determining or detecting said antibodies.

The process can be used for the determination of antitetanic antibodies in human serum.

Claims

1. In a process for coupling at least two biological substances by covalent bonds by means of a cross-linking agent, the said cross-linking agent being benzoquinone, the improvement comprising the steps of:

(a) treatment of Fab fragment of an immunoglobulin as the first substance dissolved in solution by at least about 200 times its molar amount of benzoquinone, said reaction known as the activation reaction being performed in a homogeneous liquid medium;

(b) removal of the reaction products of step (a) and the excess benzoquinone and recovery of the activated Fab fragment;

(c) contacting the activated Fab fragment with the second substance to be coupled.

2. A process according to claim 1, wherein the molar ratio of benzoquinone:

Fab fragment is up to 1000.

3. A process according to claim 1, wherein step (c) for coupling the Fab fragment after reaction with benzoquinone and the other biological substance, is carried out at room temperature until satisfactory coupling is obtained for a time in the range of from 1 to 48 hours in a buffered aqueous medium with an excess of the Fab fragment based on the other substance.

4. A process according to claim 1, wherein the activation reaction with benzoquinone is effected at a temperature not higher than 22°

C., until the coupling agent is attached to the Fab fragment, from a few minutes to 24 hours.

5. A process according to claim 1, wherein step (b) for the removal of reaction products and excess benzoquinone is performed by passing the substance through an exchange resin which is in the form of a molecular filtration column.

6. A process according to claim 1 wherein the activation reagent is parabenzoquinone.

7. A process according to claim 1, wherein the activation treatment of step (a) is effected by contacting the Fab fragment dissolved in a buffered aqueous medium, with benzoquinone in solution, in a lower aliphatic alcohol.

8. A process according to claim 7, wherein the pH of the aqueous reaction medium is in the range of from about 5.5 to about 9.

9. A process according to claim 1, wherein the second biological substance is selected from the group consisting of, red blood cells, nucleic acids and polysaccharides.

10. Th process of claim 1, wherein the second biological substance is an antigen or antibody.

11. The process of claim 10 wherein the antibody is to red blood cells, a virus, a tetanus antigen or an enzyme.

12. The process of claim 1 wherein the second biological substances is the Fab fragment of the antibody to an enzyme.

13. A process according to claim 1, wherein the said second substance is peroxidase, alkaline phosphatase, glucose oxidase, β

-galactosidase, or lactoperoxidase.